Research and future trends in the pharmaceutical development of medicinal herbs from Chinese medicine
Bibliographic Data
| ID | 15097698 |
|---|---|
| Authors | Kuo-Hsiung Lee (University of North Carolina at Chapel Hill, corresponding author) |
| Year | 2000 |
| Volume | 3 |
| Issue | 4a |
| Pages | 515-522 |
| Publication date | 2000-12-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Public Health Nutrition (JOURNAL) |
| Journal identifiers | ISSN: 1368-9800 • E-ISSN: 1475-2727 |
| Publisher | Cambridge University Press (CUP) (PUBLISHER) |
| DOI | 10.1017/s1368980000000604 |
| PMID | 11276300 |
| OpenAlex | W2070210701 |
| Language | EN |
| Citations received | 4 |
| References cited | 32 |
Issues concerning the past and future development of medicinal herbs from Chinese medicine (CM) are addressed in this paper. In the Western world, medicinal herbs are becoming increasingly popular and important in the public and scientific communities. In contrast to their regulated status in China and other countries, herbal medicines are regarded as dietary supplements in the US. Accordingly, research must continue worldwide to identify and improve the efficacy of the active principals of herbs both singly and in combination – from active ingredients, active fractions, and active herbal formulations. While Western medicine currently employs pure, single compounds, either natural or synthetic, CM has long used multiple combinations of compounds in the form of processed natural products, primarily medicinal herbs, to treat and relieve the symptoms of many different human diseases. CM may have fewer and less severe side effects than single pure drugs, making CM especially attractive to the consumer. In effect, CM's focus on combination therapy does serve both ancient and modern theories. However, research using modern analytical and chemical techniques is needed to ensure efficacy and safety, to provide qualitative and quantitative analyses for dietary supplements, and to develop new, effective and safe world-class drugs. Drug design is an iterative process. Bioactivity-directed fractionation and isolation identify active natural compounds from single herbs or formulations. These lead structures can be chemically modified and improved through knowledge of structure–activity relationship, mechanism of action, drug metabolism, molecular modelling and combinatorial chemistry studies. Finally, efficacy and toxicity determination as well as clinical trials can contribute to the generation of new drugs from CM. To continue the legacy of CM, as well as the worldwide uses of other medicinal herbs, continued investigation of active formulations, bioactive fractions, and isolated compounds is critical to drug development in the 21st century
Active ingredient · Alternative medicine · Chinese herbs · Drug · Traditional Chinese medicine · Traditional medicine · Medicine · Natural product bioactivities and synthesis · Pharmacological Effects of Natural Compounds · Phytochemistry and Biological Activities · Pharmacology
Using Chinese medicine to understand medicinal herb quality
Medicinal plants used in the management of chronic joint pains in Machakos and Makueni counties, Kenya
Arachidonic acid metabonomics study for understanding therapeutic mechanism of Huo Luo Xiao Ling Dan on rat model of rheumatoid arthritis
Contextualizing the Politics of Knowledge
| Citations per year | 0.17 |
|---|---|
| Citation span | 2002 - 2018 (17) |
| Highly cited | No |